[ Price : $8.95]
FDA grants Greenwich LifeSciences fast track status for GLSI-100 for preventing breast cancer recurrences.[ Price : $8.95]
In a new crackdown on drug advertising, FDA orders pharmaceutical companies to remove any noncompliant ads and bring all promotion...[ Price : $8.95]
Former FDA Digital Health Center of Excellence acting director Sonja Fulmer leaves the agency to accept a position at Mayo Clinic ...[ Price : $8.95]
FDA approves an expanded indication to include pediatric patients aged one and older for AstraZenecas Koselugo to treat some cases...[ Price : $8.95]
Lexicon Pharmaceuticals submits new clinical data to FDA that attempts to advance its stalled NDA for its diabetes drug Zynquist (...[ Price : $8.95]
Capricor Therapeutics posts its response to an FDA complete response letter for Bytreldo since the agency published the letter pub...[ Price : $8.95]
NRx Pharmaceuticals petitions FDA seeking a ban on all ketamine products formulated with the preservative benzethonium chloride, a...[ Price : $8.95]
The 7th Circuit Court of Appeals affirms, although for different legal reasons, a federal district court ruling rejecting a False ...